|
[1]
|
GBD 2019 Stroke Collaborators (2021) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820.
|
|
[2]
|
Shi, K., Tian, D., Li, Z., Ducruet, A.F., Lawton, M.T. and Shi, F. (2019) Global Brain Inflammation in Stroke. The Lancet Neurology, 18, 1058-1066. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Iadecola, C. and Anrather, J. (2011) The Immunology of Stroke: From Mechanisms to Translation. Nature Medicine, 17, 796-808. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Peaper, D.R. and Landry, M.L. (2014) Laboratory Diagnosis of Viral Infection. Handbook of Clinical Neurology, 123, 123-147.
|
|
[5]
|
Zhou, X., Li, P., Wu, X., Lin, X., Zhao, L., Huang, H., et al. (2022) Multifunctional Biosensor Constructed by Ag-Coating Magnetic-Assisted Unique Urchin Core Porous Shell Structure for Dual SERS Enhancement, Enrichment, and Quantitative Detection of Multi-Components Inflammatory Markers. Biosensors and Bioelectronics, 210, Article ID: 114257. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Hankey, G.J. (2006) Potential New Risk Factors for Ischemic Stroke: what Is Their Potential? Stroke, 37, 2181-2188. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kwan, J., Horsfield, G., Bryant, T., Gawne-Cain, M., Durward, G., Byrne, C.D., et al. (2013) IL-6 Is a Predictive Biomarker for Stroke Associated Infection and Future Mortality in the Elderly after an Ischemic Stroke. Experimental Gerontology, 48, 960-965. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Visser, M. (1999) Elevated C-Reactive Protein Levels in Overweight and Obese Adults. JAMA, 282, 2131-2135. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
VanGilder, R.L., Davidov, D.M., Stinehart, K.R., Huber, J.D., Turner, R.C., Wilson, K.S., et al. (2014) C-Reactive Protein and Long-Term Ischemic Stroke Prognosis. Journal of Clinical Neuroscience, 21, 547-553. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Tsimikas, S., Duff, G.W., Berger, P.B., Rogus, J., Huttner, K., Clopton, P., et al. (2014) Pro-inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a). Journal of the American College of Cardiology, 63, 1724-1734. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, Y., Meng, R., Liu, G., Cao, C., Chen, F., Jin, K., et al. (2019) Intracranial Atherosclerotic Disease. Neurobiology of Disease, 124, 118-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Su, J., Luo, M., Liang, N., Gong, S., Chen, W., Huang, W., et al. (2021) Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. Frontiers in Pharmacology, 12, Article 745061. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Koh, K.K., Han, S.H. and Quon, M.J. (2005) Inflammatory Markers and the Metabolic Syndrome: Insights from Therapeutic Interventions. Journal of the American College of Cardiology, 46, 1978-1985. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kelly, P.J., Murphy, S., Coveney, S., Purroy, F., Lemmens, R., Tsivgoulis, G., et al. (2017) Anti-Inflammatory Approaches to Ischaemic Stroke Prevention. Journal of Neurology, Neurosurgery & Psychiatry, 89, 211-218. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ridker, P.M., Everett, B.M., Thuren, T., MacFadyen, J.G., Chang, W.H., Ballantyne, C., et al. (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377, 1119-1131. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ridker, P.M., Danielson, E., Fonseca, F.A.H., Genest, J., Gotto, A.M., Kastelein, J.J.P., et al. (2008) Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine, 359, 2195-2207. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Rost, N.S., Wolf, P.A., Kase, C.S., Kelly-Hayes, M., Silbershatz, H., Massaro, J.M., et al. (2001) Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study. Stroke, 32, 2575-2579. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. and Cook, N.R. (2002) Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events. New England Journal of Medicine, 347, 1557-1565. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., et al. (2008) Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. New England Journal of Medicine, 359, 1317-1329. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ma, H., Campbell, B.C.V., Parsons, M.W., et al. (2019) Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. The New England Journal of Medicine, 380, 1795-1803.
|
|
[21]
|
Zhu, H., Hu, S., Li, Y., Sun, Y., Xiong, X., Hu, X., et al. (2022) Interleukins and Ischemic Stroke. Frontiers in Immunology, 13, Article 828447. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Alsbrook, D.L., Di Napoli, M., Bhatia, K., Biller, J., Andalib, S., Hinduja, A., et al. (2023) Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke. Current Neurology and Neuroscience Reports, 23, 407-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ramos-Fernandez, M., Bellolio, M.F. and Stead, L.G. (2011) Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review. Journal of Stroke and Cerebrovascular Diseases, 20, 47-54. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Palm, F., Pussinen, P.J., Safer, A., Tervahartiala, T., Sorsa, T., Urbanek, C., et al. (2018) Serum Matrix Metalloproteinase-8, Tissue Inhibitor of Metalloproteinase and Myeloperoxidase in Ischemic Stroke. Atherosclerosis, 271, 9-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Bonaventura, A., Liberale, L., Vecchié, A., Casula, M., Carbone, F., Dallegri, F., et al. (2016) Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke. International Journal of Molecular Sciences, 17, Article 1967. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Lambertsen, K.L., Biber, K. and Finsen, B. (2012) Inflammatory Cytokines in Experimental and Human Stroke. Journal of Cerebral Blood Flow & Metabolism, 32, 1677-1698. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lambertsen, K.L., Clausen, B.H., Babcock, A.A., Gregersen, R., Fenger, C., Nielsen, H.H., et al. (2009) Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor. The Journal of Neuroscience, 29, 1319-1330. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Nawashiro, H., Martin, D. and Hallenbeck, J.M. (1997) Neuroprotective Effects of TNF Binding Protein in Focal Cerebral Ischemia. Brain Research, 778, 265-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Chen, X., Zhang, J., Song, Y., Yang, P., Yang, Y., Huang, Z., et al. (2020) Deficiency of Anti-Inflammatory Cytokine IL-4 Leads to Neural Hyperexcitability and Aggravates Cerebral Ischemia-Reperfusion Injury. Acta Pharmaceutica Sinica B, 10, 1634-1645. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Shaafi, S., Sharifipour, E., Rahmanifar, R., et al. (2014) Interleukin-6, a Reliable Prognostic Factor for Ischemic Stroke. Iranian Journal of Neurology, 13, 70-76.
|
|
[31]
|
Pelidou, S., Kostulas, N., Matusevicius, D., Kivisäkk, P., Kostulas, V. and Link, H. (1999) High Levels of IL‐10 Secreting Cells Are Present in Blood in Cerebrovascular Diseases. European Journal of Neurology, 6, 437-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
De Bilbao, F., Arsenijevic, D., Moll, T., Garcia‐Gabay, I., Vallet, P., Langhans, W., et al. (2009) In Vivo Over‐Expression of Interleukin‐10 Increases Resistance to Focal Brain Ischemia in Mice. Journal of Neurochemistry, 110, 12-22. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Spera, P.A., Ellison, J.A., Feuerstein, G.Z. and Barone, F.C. (1998) IL-10 Reduces Rat Brain Injury Following Focal Stroke. Neuroscience Letters, 251, 189-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Frenkel, D., Huang, Z., Maron, R., Koldzic, D.N., Moskowitz, M.A. and Weiner, H.L. (2005) Neuroprotection by IL-10-Producing MOG CD4+ T Cells Following Ischemic Stroke. Journal of the Neurological Sciences, 233, 125-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhao, H., Li, F., Huang, Y., Zhang, S., Li, L., Yang, Z., et al. (2020) Prognostic Significance of Plasma IL-2 and sIL-2Rα in Patients with First-Ever Ischaemic Stroke. Journal of Neuroinflammation, 17, Article No. 237. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Martínez-Sánchez, P., Gutiérrez-Fernández, M., Fuentes, B., Masjuán, J., Cases, M.A.d.L., Novillo-López, M.E., et al. (2014) Biochemical and Inflammatory Biomarkers in Ischemic Stroke: Translational Study between Humans and Two Experimental Rat Models. Journal of Translational Medicine, 12, Article No. 220. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Hotter, B., Hoffmann, S., Ulm, L., Meisel, C., Fiebach, J.B. and Meisel, A. (2019) IL-6 Plasma Levels Correlate with Cerebral Perfusion Deficits and Infarct Sizes in Stroke Patients without Associated Infections. Frontiers in Neurology, 10, Article 83. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Shenhar-Tsarfaty, S., Assayag, E.B., Bova, I., Shopin, L., Fried, M., Berliner, S., et al. (2010) Interleukin-6 as an Early Predictor for One-Year Survival Following an Ischaemic Stroke/Transient Ischaemic Attack. International Journal of Stroke, 5, 16-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Wang, C., Gao, L., Zhang, Z., Li, Y., Yang, Y., Chang, T., et al. (2015) Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke. Molecular Neurobiology, 53, 1509-1517. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Shaheen, H.A., Daker, L.I., Abbass, M.M. and Abd El Fattah, A.A. (2018) The Relationship between the Severity of Disability and Serum IL-8 in Acute Ischemic Stroke Patients. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 54, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Murray, K.N., Parry-Jones, A.R. and Allan, S.M. (2015) Interleukin-1 and Acute Brain Injury. Frontiers in Cellular Neuroscience, 9, Article 18. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Brough, D., Tyrrell, P.J. and Allan, S.M. (2011) Regulation of Interleukin-1 in Acute Brain Injury. Trends in Pharmacological Sciences, 32, 617-622. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Smith, C.J., Emsley, H.C., Udeh, C.T., Vail, A., Hoadley, M.E., Rothwell, N.J., et al. (2012) Interleukin-1 Receptor Antagonist Reverses Stroke-Associated Peripheral Immune Suppression. Cytokine, 58, 384-389. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Zhang, H., Xia, Y., Ye, Q., Yu, F., Zhu, W., Li, P., et al. (2018) In Vivo Expansion of Regulatory T Cells with IL-2/IL-2 Antibody Complex Protects against Transient Ischemic Stroke. The Journal of Neuroscience, 38, 10168-10179. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Kim, H., Shin, H., Jeong, H., An, H., Kim, N., Chae, H., et al. (2000) Reduced IL-2 but Elevated IL-4, IL-6, and Ige Serum Levels in Patients with Cerebral Infarction during the Acute Stage. Journal of Molecular Neuroscience, 14, 191-196. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Liu, X., Liu, J., Zhao, S., Zhang, H., Cai, W., Cai, M., et al. (2016) Interleukin-4 Is Essential for Microglia/Macrophage M2 Polarization and Long-Term Recovery after Cerebral Ischemia. Stroke, 47, 498-504. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., et al. (2010) Biology of Interleukin-10. Cytokine & Growth Factor Reviews, 21, 331-344. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Li, J., Pan, Y., Xu, J., Li, S., Wang, M., Quan, K., et al. (2021) Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients. Stroke, 52, 2827-2836. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Toldo, S. and Abbate, A. (2017) The NLRP3 Inflammasome in Acute Myocardial Infarction. Nature Reviews Cardiology, 15, 203-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Tardif, J., Kouz, S., Waters, D.D., Bertrand, O.F., Diaz, R., Maggioni, A.P., et al. (2019) Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. New England Journal of Medicine, 381, 2497-2505. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Nidorf, S.M., Fiolet, A.T.L., Mosterd, A., Eikelboom, J.W., Schut, A., Opstal, T.S.J., et al. (2020) Colchicine in Patients with Chronic Coronary Disease. New England Journal of Medicine, 383, 1838-1847. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Van Gool, A., Corrales, F., Čolović, M., Krstić, D., Oliver-Martos, B., Martínez-Cáceres, E., et al. (2020) Analytical Techniques for Multiplex Analysis of Protein Biomarkers. Expert Review of Proteomics, 17, 257-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Ran, B., Zheng, W., Dong, M., Xianyu, Y., Chen, Y., Wu, J., et al. (2018) Peptide-Mediated Controllable Cross-Linking of Gold Nanoparticles for Immunoassays with Tunable Detection Range. Analytical Chemistry, 90, 8234-8240. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Kuhar, N., Sil, S., Verma, T. and Umapathy, S. (2018) Challenges in Application of Raman Spectroscopy to Biology and Materials. RSC Advances, 8, 25888-25908. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Fazio, B., D’Andrea, C., Foti, A., Messina, E., Irrera, A., Donato, M.G., et al. (2016) SERS Detection of Biomolecules at Physiological Ph via Aggregation of Gold Nanorods Mediated by Optical Forces and Plasmonic Heating. Scientific Reports, 6, Article No. 26952. [Google Scholar] [CrossRef] [PubMed]
|